Skip to main content
SpringerLink
Log in

Alectinib

Nausea: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Heath JA, et al. Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastoma. Pediatric Blood and Cancer 65: e27055, No. 7, Jul 2018. Available from: URL: http://doi.org/10.1002/pbc.27055 -Australia

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alectinib. Reactions Weekly 1755, 17 (2019). https://doi.org/10.1007/s40278-019-62571-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-62571-6

Search

Navigation